The Emerging Role of GLP-1 Agonists in Burn Care: What Do We Know?
- 15 October 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 46 (2) , 481-486
Abstract
Glucagon-like peptide-1 (GLP-1) agonists mimic the action of GLP-1, a hormone that regulates blood glucose levels via stimulation of insulin release and inhibition of glucagon secretion. After the burn, the current literature suggests that the use of GLP-1 agonists results in less insulin dependence with similar glucose control and hypoglycemic events to patients receiving a basal-bolus insulin regimen. Glucagon-like peptide-1 agonists may also promote wound healing through various mechanisms including angiogenesis and improved keratinocyte migration. Despite the potential benefits, GLP-1 agonists reduce gastrointestinal motility which impacts their widespread adoption in burn care. This dysmotility can result in inadequate nutrition delivery, unintentional weight loss, and is a potential aspiration risk. The net impact of these medications on patients with burns is unclear. Given their potential to demonstrate the safety, efficacy, and optimal dosing of various GLP-1 agonists in acute burn management.Keywords
This publication has 39 references indexed in Scilit:
- Relationship between inflammation and metabolic regulation of energy expenditure by GLP-1 in critically ill childrenClinical Nutrition, 2021
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1Cell Metabolism, 2018
- Proinflammatory switch from Gαs to Gαi signaling by Glucagon-like peptide-1 receptor in murine splenic monocyte following burn injuryInflammation Research, 2017
- Clinician’s Guide to Nutritional Therapy Following Major Burn InjuryClinics in Plastic Surgery, 2017
- Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healingJournal of Surgical Research, 2017
- The effect of local hyperglycemia on skin cells in vitro and on wound healing in euglycemic ratsJournal of Surgical Research, 2016
- GLP‐1 receptor agonists: Nonglycemic clinical effects in weight loss and beyondObesity, 2015
- Effects of GLP-1 on appetite and weightReviews in Endocrine and Metabolic Disorders, 2014
- The environment within: how gut microbiota may influence metabolism and body compositionDiabetologia, 2010
- Growth Delay in Postburn Pediatric PatientsArchives of Surgery, 1990